LEDAGA

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, UK.

Active ingredients

The drug LEDAGA contains one active pharmaceutical ingredient (API):

1	Chlormethine UNII L0MR697HHI - MECHLORETHAMINE HYDROCHLORIDE
	Chlormethine is a bifunctional alkylating agent that inhibits rapidly proliferating cells. It works by binding to DNA, crosslinking two strands and preventing cell duplication. It binds to the N7 nitrogen on the DNA base guanine. It has been derivatized into the estrogen analogue estramustine phosphate, used to treat prostate cancer.
	Read more about Chlormethine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEDAGA Gel	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AA05	Chlormethine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1739752
FI	Lääkealan turvallisuus- ja kehittämiskeskus	466667
FR	Base de données publique des médicaments	64465866
GB	Medicines & Healthcare Products Regulatory Agency	372875
IL	מִשְׂרַד הַבְּרִיאוּת	7823
IT	Agenzia del Farmaco	045315013
LT	Valstybinė vaistų kontrolės tarnyba	1082467
NL	Z-Index G-Standaard, PRK	148490
PL	Rejestru Produktów Leczniczych	100387912